Your session is about to expire
← Back to Search
Ascorbate for Bone Sarcoma
Study Summary
This trial is testing if a high dose of Vitamin C, given with the chemotherapy drug gemcitabine, is safe and effective for teens with sarcomas that have spread or can't be removed with surgery.
- Bone Sarcoma
- Soft Tissue Sarcoma
- Bone Cancer
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Have there been any other investigations into the efficacy of Ascorbate?
"As of now, 495 clinical trials related to Ascorbate are ongoing with 142 in their final phase. Although the majority of these studies occur within Woolloongabba, Queensland, a total 25057 sites across the world are hosting investigations for this therapy."
Are there still vacancies open for participants in this research trial?
"Clinicaltrials.gov data confirms that this study is no longer actively enrolling patients, as the last update was done on September 16th 2022. However, there are other medical trials currently in progress that require participants - 994 to be exact."
Does the eligibility criteria for this experiment encompass individuals under forty years of age?
"Per the trial's stated requirements, eligible candidates will be aged between 13 and 17 years old. The database lists 234 studies with participants under 18 and 862 for those over 65."
To whom is it possible to apply for this research initiative?
"This medical experiment is looking for 20 minors diagnosed with soft tissue sarcoma (STS) between the ages of 13 and 17. To be eligible, candidates must have had prior chemotherapy treatments such as methotrexate or adriamycin; should not display any residual toxicity from preceding therapies; possess measurable disease that spans at least 1 cm in length; and achieve an Eastern Cooperative Oncology Group Performance Status score of 2 or lower."
Are there any limitations on the number of people permitted to participate in this clinical experiment?
"This clinical study is no longer accepting participants. It was initially posted on January 1st 2023 and the last update occurred on September 16th 2022. If you are still seeking trials, there currently exist 499 actively recruiting patients with soft tissue sarcomas (STS) and 495 studies for Ascorbate that are open to enrollment."
To what medical ailments is Ascorbate commonly administered?
"Ascorbate is popularly used to address small cell lung cancer (sclc) but it can also be applied therapeutically in the treatment of head and neck carcinoma, cervical cancers, and catarrh."
Share this study with friends
Copy Link
Messenger